Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available?

Area of Science:

• Health economics
• Clinical implementation science
• Healthcare policy

Background:

• Effective implementation of clinical guidelines offers significant patient and economic benefits.
• Investment in implementation activities requires rigorous cost-benefit assessment.
• Natriuretic peptide (NP) testing for heart failure has variable uptake in clinical practice.

Purpose of the Study:

• To estimate the economic value of investing in implementation strategies for NP testing.
• To utilize multi-period analysis and diffusion curves for value assessment.
• To inform decisions regarding resource allocation for healthcare interventions.

Main Methods:

• Diffusion curves were generated from historical data to forecast future utilization.
• The cost-effectiveness of implementation interventions was evaluated.
• Both static population and multi-period analyses were conducted.

Main Results:

• The value of implementation interventions for NP testing decreases as natural diffusion progresses.
• Sensitivity analyses revealed that intervention efficacy and population size significantly influence value.
• Early implementation yields higher returns on investment.

Conclusions:

• Assessing the value of implementation aids policy decisions, especially with limited data.
• Multi-period analysis is crucial for accurate value quantification over time.
• Timely investment in proven interventions maximizes healthcare resource utilization and patient benefit.